|
OncoMed works with a sister company, YgeneX, to help coordinate requests by physicians for genetic molecular tests utilized to determine if the companion therapeutic has a likelihood of response by a specific patient.
- Therapeutic is not dispensed unless test results specify an indication for use
Current tests that are available:
Oncotype DX
Oncotype DX is a clinically validated laboratory test, ordered by physicians, that predicts the likelihood of breast cancer recurrence in women with newly diagnosed, early stage invasive breast cancer. Oncotype DX also assesses the benefit from chemotherapy. To learn more about Oncotype DX, please visit this website: http://www.genomichealth.com/oncotype/default.aspx
|
